FDA’s Pazdur Believes ‘Advanced Research’ Project Could Address Trial ‘Wastefulness’

 
• By Sarah Karlin-Smith
  
ARPA-H could remove waste from the clinical trial system, Pazdur suggests. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D